Related Experiment Videos
Preparation and characterization of solid lipid nanoparticles containing peptide
1School of Pharmaceutical Science, Zhejiang University, 353 Yanan Road, Hangzhou 310031, PR China. pharmnet@cps.zju.edu.cn
International Journal of Pharmaceutics
|March 11, 2004
Summary
This study developed a novel method for creating peptide-loaded solid lipid nanoparticles (SLN) for drug delivery. These SLN effectively encapsulate hydrophilic peptides, showing potential for prolonged drug release.
Area of Science:
- Pharmaceutical Sciences
- Nanotechnology
- Drug Delivery Systems
Background:
- Solid lipid nanoparticles (SLN) offer controlled drug delivery but struggle with hydrophilic peptide incorporation.
- Hydrophilic peptides are challenging to integrate into the lipophilic matrix of SLN.
Purpose of the Study:
- To develop a novel solvent diffusion method for preparing peptide-loaded SLN.
- To characterize gonadorelin-loaded SLN for entrapment efficiency, size, zeta potential, and drug release.
- To evaluate the suitability of SLN for prolonged release of hydrophilic peptides.
Main Methods:
- Peptide-loaded SLN were prepared using a novel solvent diffusion method in an aqueous system.
- Gonadorelin and monostearin were dissolved in organic solvents and poured into an aqueous solution with polyvinyl alcohol (PVA).
- SLN were separated by centrifugation and characterized for size, zeta potential, and in vitro drug release.
Main Results:
- The novel method successfully produced gonadorelin-loaded SLN with an average diameter of 421.7 nm and a zeta potential of -21.1 mV.
- Entrapment efficiency of gonadorelin reached 69.4%.
- In vitro release studies showed a biphasic pattern with a burst release followed by prolonged release over 12 days, demonstrating suitability for sustained drug delivery.
Conclusions:
- A novel and effective method for preparing peptide-loaded SLN was established.
- Solid lipid nanoparticles are suitable for the prolonged release formulation of hydrophilic peptide drugs.
- The developed SLN system shows promise for enhancing the delivery of peptide therapeutics.